Skip to main content
Global Cosmed S.A. logo

Global Cosmed S.A. — Investor Relations & Filings

Ticker · GLC ISIN · PLGLBLC00011 LEI · 2594009CXYWKREHIBZ14 WAR Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2017-12-29 Director's Dealing
Country PL Poland
Listing WAR GLC

About Global Cosmed S.A.

http://www.globalcosmed.pl/

Global Cosmed S.A. is a manufacturer of cosmetics and household chemicals. The company's business model is focused on two primary segments: the development and sale of its own proprietary brands, and the production of private label goods for national and international retailers. Its product portfolio encompasses a wide range of items in personal care, cosmetics, and home care categories. Key brands include Apart (personal care), Bobini (children's cosmetics), Sofin (fabric care), and Kret (household cleaning agents). The company distributes its products across both domestic and international markets.

Recent filings

Filing Released Lang Actions
Informacja o transakcjach wykonywanych przez osoby pełniące obowiązki zarządcze. - Content (PL)
Director's Dealing Classification · 98% confidence The document text is very short (320 characters) and explicitly states that the company received a notification from a Member of the Management Board (Członka Zarządu) regarding a transaction, as per Article 19(1) of the MAR regulation, and that the content of this notification is attached ('Emitent w załączeniu przekazuje treść Powiadomienia'). This structure—a brief announcement stating that a required disclosure (insider transaction notification) is attached—strongly suggests a Director's Dealing report being filed or announced. The specific reference to Article 19(1) of MAR (Market Abuse Regulation) confirms this relates to insider transactions by management/directors. Therefore, the appropriate classification is Director's Dealing (DIRS).
2017-12-29 Polish
Powiadomienie_o_transakcji__Andreas_Mielimonka.pdf
Director's Dealing Classification · 99% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction (Zbycie - umowy darowizny / Disposal - gift agreements) involving shares by a person discharging managerial responsibilities ('Prezes Zarządu' - CEO/President of the Management Board), Andreas Mielimonka. This structure and content precisely match the definition of Director's Dealing (insider trades) reports, which are mandated under MAR Article 19. The corresponding code is DIRS.
2017-12-29 Polish
Informacja o transakcjach wykonywanych przez osoby pełniące obowiązki zarządcze. - Content (PL)
Director's Dealing Classification · 95% confidence The document text is very short (313 characters) and explicitly states that the Issuer ("Emitent") received a notification regarding a transaction by the CEO, as per Article 19(1) of the MAR regulation, and that the Issuer is enclosing the content of the Notification ("Emitent w załączeniu przekazuje treść Powiadomienia"). This structure—announcing the receipt of a transaction notice and attaching the details—is characteristic of insider trading reports. Specifically, Article 19 of MAR deals with transactions by persons discharging managerial responsibilities. The closest category for reporting personal share transactions by directors/executives is 'Director's Dealing' (DIRS). Since the document is an announcement enclosing the actual notification, it could potentially be RPA, but given the specific nature of the content (insider transaction notification), DIRS is the most accurate classification for the subject matter being reported, even if the format is a brief announcement.
2017-12-29 Polish
Rejestracja obniżenia kapitału zakładowego w jednostce zależnej. - Content (PL)
Share Issue/Capital Change Classification · 98% confidence The document is a regulatory announcement from Global Cosmed S.A. informing the market that the share capital reduction of its subsidiary, GCG SA, has been registered by the National Court Register (KRS). The text explicitly details the reduction amount (from PLN 121,300,923.00 to PLN 90,717,383.00) and the mechanism (cancellation/redemption of specific series of shares) related to a corporate spin-off/division. This action directly concerns the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes to the capital structure, including reductions via share cancellation.
2017-12-21 Polish
Nabycie aktywów o znacznej wartości przez jednostkę zależną od Emitenta - Content (PL)
M&A Activity Classification · 95% confidence The document text, written in Polish, describes a transaction where a subsidiary of the Issuer (Emitent) acquired 25% of the shares in another company (Global Cosmed Group GmbH) from a member of the Issuer's Management Board (Artur Rafael Mielimonka). This acquisition resulted in the subsidiary increasing its ownership from 75% to 100% in the target company. The transaction involved the issuance of new shares (Series B) in exchange for the acquired shares. This clearly details a significant change in capital structure, ownership, and a transaction involving insiders/management. This fits the description of a Capital/Financing Update (CAP) or potentially a Major Shareholding Notification (MRQ) or Transaction in Own Shares (POS) if the issuance was considered a buyback/issuance, but the core event is the acquisition of a significant asset/stake leading to a change in control/structure. Given the focus on acquiring shares and issuing new shares in exchange, 'Capital/Financing Update' (CAP) is the most appropriate fit, as it involves a change in capital structure via share issuance to facilitate an acquisition. It is not a standard Director's Dealing (DIRS) as it's a corporate transaction involving share issuance, nor is it a simple M&A announcement (TAR) as it details the specific financing mechanism used.
2017-12-19 Polish
2017Q3_GRUPA_KAPITALOWA_GLOBAL_COSMED.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowany raport kwartalny' (Consolidated Quarterly Report) for Global Cosmed S.A. covering the period ending September 30, 2017. It contains detailed financial statements, including the statement of financial position, income statement, cash flow statement, and notes to the financial statements. As it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it fits the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-20 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.